Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NITROFURANTOIN vs NIVOLUMAB\RELATLIMAB-RMBW: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

NITROFURANTOIN vs NIVOLUMAB\RELATLIMAB-RMBW: Safety Overview

Metric NITROFURANTOIN NIVOLUMAB\RELATLIMAB-RMBW
Total FAERS Reports 5,073 500
Deaths Reported 256 120
Death Rate 5.0% 24.0%
Hospitalizations 1,615 147
Average Patient Age 61.4 yrs 64.8 yrs
% Female Patients 87.9% 33.2%
FDA Approval Date Approved Prior to Jan 1, 1982 N/A
Manufacturer Proficient Rx LP N/A
Route ORAL N/A
Marketing Status Discontinued N/A